
Innovotech Inc (IOT:CVE) - Strategic SWOT Spotlight
Description
Report Spotlight
Innovotech Inc (IOT:CVE) - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Innovotech Inc's business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.
Key Highlights
Innovotech Inc., incorporated in 2003, is a Canadian biotechnology company headquartered in Edmonton, Alberta. The company focuses on antimicrobial research and biofilm-related solutions, serving clients across the medical, industrial, and agricultural sectors. Innovotech provides specialized contract research services and develops proprietary technologies that address the growing global concern of biofilm-associated infections and contamination. Its flagship product, the MBEC Assay Kit, is widely used in laboratories to test the effectiveness of antimicrobial agents against biofilms. Innovotech has expanded its geographic presence primarily across North America, supporting both public and private sector organizations. In 2024, the company acquired Keystone Labs Inc., a government-licensed laboratory, enhancing its testing capabilities and expanding its client base.
Innovotech Inc in the News:-
Company Fundamentals:- These fundamentals offer valuable insights into Innovotech Inc (IOT:CVE)'s operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.
Reasons to Buy
Innovotech Inc (IOT:CVE) - Strategic SWOT Spotlight is a comprehensive and easily accessible overview of The Innovotech Inc's business operations. It provides a Snapshot of the company's position in the industry compared to competitors. The report includs key executives, products and services, ESG spotlight, Corporate Strategy, Business Description, Helicopter view of SWOT Analysis, Competitive Landscape and latest events.
Key Highlights
Innovotech Inc., incorporated in 2003, is a Canadian biotechnology company headquartered in Edmonton, Alberta. The company focuses on antimicrobial research and biofilm-related solutions, serving clients across the medical, industrial, and agricultural sectors. Innovotech provides specialized contract research services and develops proprietary technologies that address the growing global concern of biofilm-associated infections and contamination. Its flagship product, the MBEC Assay Kit, is widely used in laboratories to test the effectiveness of antimicrobial agents against biofilms. Innovotech has expanded its geographic presence primarily across North America, supporting both public and private sector organizations. In 2024, the company acquired Keystone Labs Inc., a government-licensed laboratory, enhancing its testing capabilities and expanding its client base.
Innovotech Inc in the News:-
- 03-Feb-2025 - Innovotech Inc. expands lab space and staff to meet its 2025 contract research pipeline
- 13-Jan-2025 - Innovotech Inc. appoints Mr. Brad Clark, CPA, CBV to its Board of Directors and creates new operating subsidiary to prepare for growth.
- 07-Jan-2025 - Innovotech Inc. Reports Issue of European Patent for Antimicrobial Silver Periodate Compounds Coated onto Polymers for Medical Devices
- 16-Jul-2024 - Innovotech Announces Annual General and Special Meeting Results
- 18-Jun-2024 - InnovoSIL-1 Antimicrobial Silver Shown to Kill COVID-19, Norovirus and Other Medically Important Viruses
Company Fundamentals:- These fundamentals offer valuable insights into Innovotech Inc (IOT:CVE)'s operations, geographical presence, products and services, ESG spotlight, Corporate Strategy, Business Description and SWOT spotlight, aiding in a comprehensive understanding of the organization.
Reasons to Buy
- Helicopter view of company's internal and external factors through SWOT analysis - Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers. - Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations. - Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Table of Contents
53 Pages
- Table of Contents
- Tables
- Charts
- Innovotech Inc - Key Company Facts
- Innovotech Inc - Company Description
- Innovotech Inc - Top Executives
- Innovotech Inc - Head Office & Locations
- Head Office - Country
- Innovotech Inc - Products and Services
- Products
- Services
- Innovotech Inc - Corporate Strategy
- Innovotech Inc - Business Description
- Innovotech Segment
- Keystone Labs Segment
- Innovotech Inc - ESG Spotlight
- Environment
- Social
- Corporate Governance
- Innovotech Inc - SWOT Spotlight
- Overview
- Strengths
- Weaknesses
- Opportunities
- Threats
- Competing Players
- Snapshot of Competing Players
- Pacific Biosciences of California Inc
- Key Company Facts
- Company Description
- Key Financials
- Share Price Trend - May-2024 to Jun-2025 (Average Share Closing Price)
- Key Financial Ratio Analysis
- Key Financial Ratio
- Charts
- Activity Ratio
- Charts
- Growth Ratios
- Charts
- Leverage Ratio
- Charts
- Liquidity Ratio
- Charts
- Profitability Ratio
- Charts
- Key Financials
- Share Price Trend - Jun-2024 to Jun-2025 (Average Share Closing Price)
- Key Financials
- Share Price Trend - Jun-2024 to Jun-2025 (Average Share Closing Price)
- Innovotech Inc - In the News 03-Feb-2025- Innovotech Inc. expands lab space and staff to meet its 2025 contract research pipeline
- 13-Jan-2025- Innovotech Inc. appoints Mr. Brad Clark, CPA, CBV to its Board of Directors and creates new operating subsidiary to prepare for growth. 07-Jan-2025- Innovotech Inc. Reports Issue of European Patent for Antimicrobial Silver Periodate Compounds Coated onto Polymers for Medical Devices
- 16-Jul-2024- Innovotech Announces Annual General and Special Meeting Results
- 18-Jun-2024- InnovoSIL-1 Antimicrobial Silver Shown to Kill COVID-19, Norovirus and Other Medically Important Viruses
- Innovotech Inc - Key Deals
- 21-Oct-2024 - Innovotech Inc. signs Definitive Agreement to acquire Keystone Labs Inc
- Appendix
- Definitions
- SWOT Analysis
- PESTLE Analysis
- Value Chain Analysis
- ESG Spotlight
- Research Methodology
- Disclaimer
- Contact Us
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.